Evidence map›Paper›PMID 31035677›Full record

ReviewInternational journal of molecular sciences2019

An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis.

Sushmita Chakraborty, Katharina F Kubatzky, Dipendra Kumar Mitra

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Interleukin-9 Facilitates Osteoclastogenesis in Rheumatoid Arthritis.International journal of molecular sciences · 2021
    Trial
  2. Review
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Neuroimmune interplay in kidney health and disease: Role of renal nerves.Autonomic neuroscience : basic & clinical · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sushmita ChakrabortyDepartment of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 1100029, India. sushmita.pahari@gmail.com.ORCID 0000-0002-0255-9532
Katharina F KubatzkyZentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany. kubatzky@uni-heidelberg.de.ORCID 0000-0003-3739-9329
Dipendra Kumar MitraDepartment of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 1100029, India. salilmitra2@gmail.com.

Funding

DBT India Alliance IA/E/16/1/503016DBT-Wellcome Trust India Alliance IA/E/16/1/503016
6 · The paper itself

Abstract

Interleukin-9 (IL-9) is a pleiotropic cytokine and was primarily studied in the context of T helper 2 (T

Indexed as

Disease SusceptibilityGene Expression RegulationSignal TransductionAnimalsBiomarkersHumansImmune ToleranceInflammationInterleukin-9Receptors, Interleukin-9T-Lymphocytes, Helper-InducerBiomarkersInterleukin-9Receptors, Interleukin-9inflammatory diseasesinterleukin-9signal transduction

Identifiers

PMID31035677
PMCPMC6522352

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.